Terms: = Prostate cancer AND NT5C2, ENSG00000076685, 22978, P49902, PNT5, NT5B, GMP, cN-II
47 results:
1. Fully closed and automated enrichment of primary blood dendritic cells for cancer immunotherapy.
Schreibelt G; Duiveman-de Boer T; Pots JM; van Oorschot TGM; de Boer AJ; Scharenborg NM; van de Rakt MWMM; Bos K; de Goede AL; Petry K; Brüning M; Angerer C; Schöggl C; Dzionek A; de Vries IJM
Methods Cell Biol; 2024; 183():33-50. PubMed ID: 38548417
[TBL] [Abstract] [Full Text] [Related]
2. Microvascular proliferation is associated with high tumour blood flow by mpMRI and disease progression in primary prostate cancer.
Børretzen A; Reisæter LAR; Ringheim A; Gravdal K; Haukaas SA; Fasmer KE; Haldorsen IHS; Beisland C; Akslen LA; Halvorsen OJ
Sci Rep; 2023 Oct; 13(1):17949. PubMed ID: 37863961
[TBL] [Abstract] [Full Text] [Related]
3. A novel direction modulated brachytherapy technique for urethra sparing in high-dose-rate brachytherapy of prostate cancer.
Meftahi M; Qiu RLJ; Patel P; Song WY; Yang X
Radiother Oncol; 2023 Sep; 186():109801. PubMed ID: 37423478
[TBL] [Abstract] [Full Text] [Related]
4. Development of in-House Synthesis and Quality Control of [
Plhak E; Pichler C; Gößnitzer E; Aigner RM; Kvaternik H
Molecules; 2023 Jan; 28(2):. PubMed ID: 36677636
[TBL] [Abstract] [Full Text] [Related]
5. The cGAS-STING pathway-related gene signature can predict patient prognosis and immunotherapy responses in prostate adenocarcinoma.
Zhuo X; Dai H; Yu S
Medicine (Baltimore); 2022 Dec; 101(50):e31290. PubMed ID: 36550819
[TBL] [Abstract] [Full Text] [Related]
6. A Brief Review of Radioactive Materials for Therapeutic and Diagnostic Purposes.
Bharti M; Alam MA; Rao GSNK; Sharma PK
Curr Radiopharm; 2023; 16(1):23-37. PubMed ID: 36306460
[TBL] [Abstract] [Full Text] [Related]
7. Whole-exome sequencing reveals a comprehensive germline mutation landscape and identifies twelve novel predisposition genes in Chinese prostate cancer patients.
Liang Y; Chiu PK; Zhu Y; Wong CY; Xiong Q; Wang L; Teoh JY; Cao Q; Wei Y; Ye DW; Tsui SK; Ng CF
PLoS Genet; 2022 Sep; 18(9):e1010373. PubMed ID: 36095024
[TBL] [Abstract] [Full Text] [Related]
8. Identification of Cytosolic DNA Sensor cGAS-STING as Immune-Related Risk Factor in Renal Carcinoma following Pan-cancer Analysis.
Wu Z; Lin Y; Liu LM; Hou YL; Qin WT; Zhang L; Jiang SH; Yang Q; Bai YR
J Immunol Res; 2022; 2022():7978042. PubMed ID: 35983076
[TBL] [Abstract] [Full Text] [Related]
9. Functional characteristics and research trends of PDE11A in human diseases (Review).
Kong G; Lee H; Vo TT; Juang U; Kwon SH; Park J; Park J; Kim SH
Mol Med Rep; 2022 Oct; 26(4):. PubMed ID: 35929507
[TBL] [Abstract] [Full Text] [Related]
10. Epitope spreading driven by the joint action of CART cells and pharmacological STING stimulation counteracts tumor escape via antigen-loss variants.
Conde E; Vercher E; Soria-Castellano M; Suarez-Olmos J; Mancheño U; Elizalde E; Rodriguez ML; Glez-Vaz J; Casares N; Rodríguez-García E; Hommel M; González-Aseguinolaza G; Uranga-Murillo I; Pardo J; Alkorta G; Melero I; Lasarte J; Hervas-Stubbs S
J Immunother Cancer; 2021 Nov; 9(11):. PubMed ID: 34810235
[TBL] [Abstract] [Full Text] [Related]
11. Pharmaceutical good manufacturing practice: Leuplin
Wada M; Ozaki A; Miyachi T; Tanimoto T; Crump A
Invest New Drugs; 2021 Aug; 39(4):1167-1169. PubMed ID: 33559805
[TBL] [Abstract] [Full Text] [Related]
12.
Fischer K; Tschismarov R; Pilz A; Straubinger S; Carotta S; McDowell A; Decker T
Front Immunol; 2020; 11():571334. PubMed ID: 33178195
[No Abstract] [Full Text] [Related]
13. Effect of HIV-1 TAT Peptide Fusion on 5' mRNA Cap Analogs Cell Membrane Permeability and Translation Inhibition.
Piecyk K; Pietrow P; Arnold T; Worch R; Korneeva NL; Jankowska-Anyszka M
Bioconjug Chem; 2020 Apr; 31(4):1156-1166. PubMed ID: 32227927
[TBL] [Abstract] [Full Text] [Related]
14. Technique development of 3D dynamic CS-EPSI for hyperpolarized
Chen HY; Larson PEZ; Gordon JW; Bok RA; Ferrone M; van Criekinge M; Carvajal L; Cao P; Pauly JM; Kerr AB; Park I; Slater JB; Nelson SJ; Munster PN; Aggarwal R; Kurhanewicz J; Vigneron DB
Magn Reson Med; 2018 Nov; 80(5):2062-2072. PubMed ID: 29575178
[TBL] [Abstract] [Full Text] [Related]
15. Intratumoral STING Activation with T-cell Checkpoint Modulation Generates Systemic Antitumor Immunity.
Ager CR; Reilley MJ; Nicholas C; Bartkowiak T; Jaiswal AR; Curran MA
Cancer Immunol Res; 2017 Aug; 5(8):676-684. PubMed ID: 28674082
[TBL] [Abstract] [Full Text] [Related]
16. Molecular, cellular and pharmacological effects of platinum(II) diiodido complexes containing 9-deazahypoxanthine derivatives: A group of broad-spectrum anticancer active agents.
Vančo J; Trávníček Z; Křikavová R; Gáliková J; Dvořák Z; Chalupová M
J Photochem Photobiol B; 2017 Aug; 173():423-433. PubMed ID: 28662469
[TBL] [Abstract] [Full Text] [Related]
17. Full preclinical validation of the 123I-labeled anti-PSMA antibody fragment ScFvD2B for prostate cancer imaging.
Frigerio B; Franssen G; Luison E; Satta A; Seregni E; Colombatti M; Fracasso G; Valdagni R; Mezzanzanica D; Boerman O; Canevari S; Figini M
Oncotarget; 2017 Feb; 8(7):10919-10930. PubMed ID: 28051996
[TBL] [Abstract] [Full Text] [Related]
18. Molecular Pathways: Targeting the Stimulator of Interferon Genes (STING) in the Immunotherapy of cancer.
Corrales L; Gajewski TF
Clin Cancer Res; 2015 Nov; 21(21):4774-9. PubMed ID: 26373573
[TBL] [Abstract] [Full Text] [Related]
19. Bench to bedside development of gmp grade Rhenium-188-HEDP, a radiopharmaceutical for targeted treatment of painful bone metastases.
ter Heine R; Lange R; Breukels OB; Bloemendal HJ; Rummenie RG; Wakker AM; de Graaf H; Beekman FJ; van der Westerlaken MM; Malingré MM; Wielders JP; van den Berg L; Hendrikse NH; de Klerk JM
Int J Pharm; 2014 Apr; 465(1-2):317-24. PubMed ID: 24560635
[TBL] [Abstract] [Full Text] [Related]
20. Pro-survival and pro-growth effects of stress-induced nitric oxide in a prostate cancer photodynamic therapy model.
Bhowmick R; Girotti AW
Cancer Lett; 2014 Feb; 343(1):115-22. PubMed ID: 24080338
[TBL] [Abstract] [Full Text] [Related]
[Next]
